For citations:
Khatkov I.E., Andreashkina I.I., Trotsenko I.D., Matveeva O.N., Reznikov V.A. Clinical and demographic characteristics and treatment patterns of patients with HR+ HER2– locally advanced or metastatic breast cancer receiving CDK4/6 inhibitors in real-world clinical practice in Moscow: data from the ICEDORA study. Real-World Data & Evidence. 2026;6(1):71-89. (In Russ.) https://doi.org/10.37489/2782-3784-myrwd-098. EDN: BWACFS
JATS XML
Email this article 
Post a Comment 